06160.HK
BeOne Medicines Ltd.
HKSE · Healthcare · Biotechnology · CH
HKD 221.40
−0.36%Forward multiples
Based on analyst estimates
- P/E forward
- 43.71x
- P/E 2026E
- 50.54x
- P/E 2027E
- 35.84x
- P/E 2028E
- 26.78x
- P/S forward
- 5.49x
Trailing multiples
Trailing twelve months
- P/E TTM
- 62.04x
- PEG TTM
- 1.48x
- Price / book
- 7.87x
- Price / sales
- 6.65x
- Price / cash flow
- 27.35x
Enterprise value
- Enterprise value
- HKD 288.3B
- EV / sales
- 6.00x
- EV / EBITDA
- 33.29x
- EV / EBIT
- 39.86x
- Market cap
- HKD 319.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026